Riverhead Capital Management’s Novartis NVS Stock Holding History

Riverhead Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.18M	Buy	13,597 +1,508	+12%	+$135K	0.04%	454
2019 Q2	$1.1M	Buy	12,089 +5,941	+97%	+$503K	0.04%	465
2019 Q1	$530K	Buy	6,148 +1,822	+42%	+$146K	0.02%	684
2018 Q4	$333K	Sell	4,326 -9,066	-68%	-$706K	0.02%	830
2018 Q3	$1.03M	Buy	13,392 +750	+6%	+$55.4K	0.04%	477
2018 Q2	$856K	Buy	12,642 +812	+7%	+$56K	0.03%	493
2018 Q1	$857K	Buy	11,830 +1,340	+13%	+$102K	0.04%	472
2017 Q4	$789K	Hold	10,490	–	–	0.03%	498
2017 Q3	$807K	Hold	10,490	–	–	0.04%	462
2017 Q2	$785K	Hold	10,490	–	–	0.04%	451
2017 Q1	$698K	Hold	10,490	–	–	0.04%	446
2016 Q4	$685K	Hold	10,490	–	–	0.04%	420
2016 Q3	$742K	Buy	10,490 +9,164	+691%	+$668K	0.05%	375
2016 Q2	$77K	Sell	1,326 -65,701	-98%	-$4.54M	﹤0.01%	1239
2016 Q1	$4.35M	Sell	67,027 -2,611	-4%	-$178K	0.06%	348
2015 Q4	$5.37M	Hold	69,638	–	–	0.08%	314
2015 Q3	$5.74M	Hold	69,638	–	–	0.09%	282
2015 Q2	$6.14M	Hold	69,638	–	–	0.09%	281
2015 Q1	$6.15M	Hold	69,638	–	–	0.09%	278
2014 Q4	$5.78M	Hold	69,638	–	–	0.09%	278
2014 Q3	$5.87M	Hold	69,638	–	–	0.1%	264
2014 Q2	$5.65M	Hold	69,638	–	–	0.11%	261
2014 Q1	$5.31M	Buy	+69,638	New	+$5.07M	0.12%	239
2013 Q3	–	Sell	-33,480	Closed	-$2.12M	–	437
2013 Q2	$2.12M	Buy	+33,480	New	+$2.18M	0.07%	266

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Riverhead Capital Management's NVS Position: Q3 2019 in Review

Riverhead Capital Management increased its Novartis (NVS) stake by 12% in Q3 2019, buying an estimated $135K and bringing the position to 13,597 shares worth $1.18M. The position accounts for 0.04% of the portfolio, ranked #454.

Riverhead Capital Management first reported a position in NVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.15M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Riverhead Capital Management held 13,597 shares of Novartis worth $1.18M as of Q3 2019.
Riverhead Capital Management bought 1,508 Novartis shares in Q3 2019, an estimated $135K.
Novartis made up 0.04% of Riverhead Capital Management's portfolio in Q3 2019, its #454 holding.
Riverhead Capital Management first reported a position in Novartis in Q2 2013 and has held it in 24 quarters since.
Riverhead Capital Management's Novartis position peaked at $6.15M in Q1 2015.
1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.